TCL Archive Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival March 28, 2014
TCL Archive Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus June 6, 2014
TCL Archive Rauscher Tells Flood Subcommittee How He Would Spend An Extra $50 Million-On Centers, Grants April 12, 1974